Home > slashdot > FDA Approves Vaccine For Prostate Cancer

FDA Approves Vaccine For Prostate Cancer

April 29th, 2010 04:23 admin Leave a comment Go to comments

reverseengineer writes “The US Food and Drug Administration has given its first first approval for a therapeutic cancer vaccine. In a clinical trial ‘involving 512 men, those who got Provenge (sipuleucel-T) had a median survival of 25.8 months after treatment while those who got a placebo lived a median of 21.7 months. After three years, 32 percent of those who got Provenge were alive, compared with 23 percent of those who got the placebo. … “The big story here is that this is the first proof of principle and proof that immunotherapy works in general in cancer, which I think is a huge observation,” said Dr. Philip Kantoff, chief of solid tumor oncology at the Dana-Farber Cancer Institute in Boston and the lead investigator in Dendreon’s largest clinical trial for the drug. “I think this is a very big thing and will lead to a lot more enthusiasm for the approach.”‘

Source: FDA Approves Vaccine For Prostate Cancer

Related Articles:

  1. With Prostate Cancer “Vaccine,” Immune System Wages War Against Tumors
  2. In Mice, Breast Cancer “Vaccine” Trains the Body to Fight Cancerous Cells
  3. Cheap Cancer Drug Finally Tested In Humans
  4. HIV Vaccine Trial Shows 90% Immune Response
  5. HIV Vaccine Approval For Human Trials
blog comments powered by Disqus